BackApexigen Overview

Apexigen Operating Income

Track Apexigen's operating income ($-28M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-6158000.00
99.65% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$-27823000.00
98.46% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Apexigen (APGN) FAQ

The latest operating income for APGN is $-28M as of June 2023. That compares with $-1.8B in the prior-year period — up 98.5% year over year. Investors often review this figure alongside Apexigen's historical trend and sector peers before judging valuation or financial health.

Over the past year, APGN's operating income moved from $-1.8B to $-28M — a 98.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Apexigen's operating scale or balance-sheet position.

A operating income figure of $-28M for APGN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting APGN's operating income ($-28M), review year-over-year change from $-1.8B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.